{"entity":{"type":"insider","cik":"0001644087","url":"/insider/0001644087","json_url":"/insider/0001644087.json","name":"Donovan Joanne M.","name_source":"as-filed","also_issuer":false,"cross_url":null},"coverage_statement":{"n_transactions":17,"n_filings":11,"first":"2023-05-03","last":"2026-08-14","span_basis":"filed_date"},"name_variants":[{"name":"Donovan Joanne M.","source":"filing","n_filings":11,"first_seen":"2023-05-03","last_seen":"2026-08-14"}],"transactions":[{"id":9294041,"accession":"0001644087-26-000005","txn_seq":5,"anchor":"line-5","filing_url":"/filing/0001644087-26-000005","line_url":"/filing/0001644087-26-000005#line-5","is_derivative":false,"issuer_cik":"0001644087","issuer_name":"Edgewise Therapeutics, Inc.","issuer_ticker":"EWTX","issuer_name_source":null,"issuer_url":"/issuer/0001644087","owner_cik":"0001644087","owner_name":"Donovan Joanne M.","owner_url":"/insider/0001644087","role":"Officer (CMO)","officer_title":"CMO","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":2919.0,"shares_display":"2,919","price_per_share":43.4065,"price_display":"43.41","price_state":"stated","total_value":126703.5735,"total_display":"126,703.57","shares_owned_after":8625.0,"shares_owned_after_display":"8,625","ownership_form":"D","is_10b5_1":null,"transaction_date":"2026-08-13","filed_date":"2026-08-14","scope":"insider"},{"id":9294040,"accession":"0001644087-26-000005","txn_seq":4,"anchor":"line-4","filing_url":"/filing/0001644087-26-000005","line_url":"/filing/0001644087-26-000005#line-4","is_derivative":false,"issuer_cik":"0001644087","issuer_name":"Edgewise Therapeutics, Inc.","issuer_ticker":"EWTX","issuer_name_source":null,"issuer_url":"/issuer/0001644087","owner_cik":"0001644087","owner_name":"Donovan Joanne M.","owner_url":"/insider/0001644087","role":"Officer (CMO)","officer_title":"CMO","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":800.0,"shares_display":"800","price_per_share":44.5175,"price_display":"44.52","price_state":"stated","total_value":35614.0,"total_display":"35,614.00","shares_owned_after":11544.0,"shares_owned_after_display":"11,544","ownership_form":"D","is_10b5_1":null,"transaction_date":"2026-08-12","filed_date":"2026-08-14","scope":"insider"},{"id":9294039,"accession":"0001644087-26-000005","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001644087-26-000005","line_url":"/filing/0001644087-26-000005#line-2","is_derivative":false,"issuer_cik":"0001644087","issuer_name":"Edgewise Therapeutics, Inc.","issuer_ticker":"EWTX","issuer_name_source":null,"issuer_url":"/issuer/0001644087","owner_cik":"0001644087","owner_name":"Donovan Joanne M.","owner_url":"/insider/0001644087","role":"Officer (CMO)","officer_title":"CMO","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":2779.0,"shares_display":"2,779","price_per_share":43.7073,"price_display":"43.71","price_state":"stated","total_value":121462.5867,"total_display":"121,462.59","shares_owned_after":12448.0,"shares_owned_after_display":"12,448","ownership_form":"D","is_10b5_1":null,"transaction_date":"2026-08-12","filed_date":"2026-08-14","scope":"insider"},{"id":9294038,"accession":"0001644087-26-000005","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001644087-26-000005","line_url":"/filing/0001644087-26-000005#line-1","is_derivative":false,"issuer_cik":"0001644087","issuer_name":"Edgewise Therapeutics, Inc.","issuer_ticker":"EWTX","issuer_name_source":null,"issuer_url":"/issuer/0001644087","owner_cik":"0001644087","owner_name":"Donovan Joanne M.","owner_url":"/insider/0001644087","role":"Officer (CMO)","officer_title":"CMO","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":2839.0,"shares_display":"2,839","price_per_share":43.784,"price_display":"43.78","price_state":"stated","total_value":124302.776,"total_display":"124,302.78","shares_owned_after":15227.0,"shares_owned_after_display":"15,227","ownership_form":"D","is_10b5_1":null,"transaction_date":"2026-08-12","filed_date":"2026-08-14","scope":"insider"},{"id":9294037,"accession":"0001644087-26-000005","txn_seq":3,"anchor":"line-3","filing_url":"/filing/0001644087-26-000005","line_url":"/filing/0001644087-26-000005#line-3","is_derivative":false,"issuer_cik":"0001644087","issuer_name":"Edgewise Therapeutics, Inc.","issuer_ticker":"EWTX","issuer_name_source":null,"issuer_url":"/issuer/0001644087","owner_cik":"0001644087","owner_name":"Donovan Joanne M.","owner_url":"/insider/0001644087","role":"Officer (CMO)","officer_title":"CMO","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":104.0,"shares_display":"104","price_per_share":44.4253,"price_display":"44.43","price_state":"stated","total_value":4620.2312,"total_display":"4,620.23","shares_owned_after":12344.0,"shares_owned_after_display":"12,344","ownership_form":"D","is_10b5_1":null,"transaction_date":"2026-08-12","filed_date":"2026-08-14","scope":"insider"},{"id":5746493,"accession":"0001644087-26-000004","txn_seq":3,"anchor":"line-3","filing_url":"/filing/0001644087-26-000004","line_url":"/filing/0001644087-26-000004#line-3","is_derivative":false,"issuer_cik":"0001644087","issuer_name":"Edgewise Therapeutics, Inc.","issuer_ticker":"EWTX","issuer_name_source":null,"issuer_url":"/issuer/0001644087","owner_cik":"0001644087","owner_name":"Donovan Joanne M.","owner_url":"/insider/0001644087","role":"Officer (CMO)","officer_title":"CMO","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":50000.0,"shares_display":"50,000","price_per_share":38.568,"price_display":"38.57","price_state":"stated","total_value":1928400.0,"total_display":"1,928,400.00","shares_owned_after":4367.0,"shares_owned_after_display":"4,367","ownership_form":"D","is_10b5_1":null,"transaction_date":"2026-05-05","filed_date":"2026-05-05","scope":"insider"},{"id":5746488,"accession":"0001644087-26-000004","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001644087-26-000004","line_url":"/filing/0001644087-26-000004#line-1","is_derivative":false,"issuer_cik":"0001644087","issuer_name":"Edgewise Therapeutics, Inc.","issuer_ticker":"EWTX","issuer_name_source":null,"issuer_url":"/issuer/0001644087","owner_cik":"0001644087","owner_name":"Donovan Joanne M.","owner_url":"/insider/0001644087","role":"Officer (CMO)","officer_title":"CMO","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":5230.0,"shares_display":"5,230","price_per_share":31.2931,"price_display":"31.29","price_state":"stated","total_value":163662.913,"total_display":"163,662.91","shares_owned_after":4367.0,"shares_owned_after_display":"4,367","ownership_form":"D","is_10b5_1":null,"transaction_date":"2026-05-04","filed_date":"2026-05-05","scope":"insider"},{"id":5910184,"accession":"0001644087-26-000003","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001644087-26-000003","line_url":"/filing/0001644087-26-000003#line-2","is_derivative":false,"issuer_cik":"0001644087","issuer_name":"Edgewise Therapeutics, Inc.","issuer_ticker":"EWTX","issuer_name_source":null,"issuer_url":"/issuer/0001644087","owner_cik":"0001644087","owner_name":"Donovan Joanne M.","owner_url":"/insider/0001644087","role":"Officer (CMO)","officer_title":"CMO","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":28662.0,"shares_display":"28,662","price_per_share":32.3109,"price_display":"32.31","price_state":"stated","total_value":926095.0158,"total_display":"926,095.02","shares_owned_after":9597.0,"shares_owned_after_display":"9,597","ownership_form":"D","is_10b5_1":null,"transaction_date":"2026-04-01","filed_date":"2026-04-02","scope":"insider"},{"id":5967668,"accession":"0001644087-26-000002","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001644087-26-000002","line_url":"/filing/0001644087-26-000002#line-2","is_derivative":false,"issuer_cik":"0001644087","issuer_name":"Edgewise Therapeutics, Inc.","issuer_ticker":"EWTX","issuer_name_source":null,"issuer_url":"/issuer/0001644087","owner_cik":"0001644087","owner_name":"Donovan Joanne M.","owner_url":"/insider/0001644087","role":"Officer (CMO)","officer_title":"CMO","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":21338.0,"shares_display":"21,338","price_per_share":32.1168,"price_display":"32.12","price_state":"stated","total_value":685308.2784,"total_display":"685,308.28","shares_owned_after":9597.0,"shares_owned_after_display":"9,597","ownership_form":"D","is_10b5_1":null,"transaction_date":"2026-03-31","filed_date":"2026-03-31","scope":"insider"},{"id":5757784,"accession":"0001644087-26-000001","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001644087-26-000001","line_url":"/filing/0001644087-26-000001#line-2","is_derivative":false,"issuer_cik":"0001644087","issuer_name":"Edgewise Therapeutics, Inc.","issuer_ticker":"EWTX","issuer_name_source":null,"issuer_url":"/issuer/0001644087","owner_cik":"0001644087","owner_name":"Donovan Joanne M.","owner_url":"/insider/0001644087","role":"Officer (CMO)","officer_title":"CMO","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":9623.0,"shares_display":"9,623","price_per_share":30.9778,"price_display":"30.98","price_state":"stated","total_value":298099.3694,"total_display":"298,099.37","shares_owned_after":16332.0,"shares_owned_after_display":"16,332","ownership_form":"D","is_10b5_1":null,"transaction_date":"2026-03-27","filed_date":"2026-03-30","scope":"insider"},{"id":5757783,"accession":"0001644087-26-000001","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001644087-26-000001","line_url":"/filing/0001644087-26-000001#line-1","is_derivative":false,"issuer_cik":"0001644087","issuer_name":"Edgewise Therapeutics, Inc.","issuer_ticker":"EWTX","issuer_name_source":null,"issuer_url":"/issuer/0001644087","owner_cik":"0001644087","owner_name":"Donovan Joanne M.","owner_url":"/insider/0001644087","role":"Officer (CMO)","officer_title":"CMO","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":6735.0,"shares_display":"6,735","price_per_share":30.9778,"price_display":"30.98","price_state":"stated","total_value":208635.483,"total_display":"208,635.48","shares_owned_after":9597.0,"shares_owned_after_display":"9,597","ownership_form":"D","is_10b5_1":null,"transaction_date":"2026-03-27","filed_date":"2026-03-30","scope":"insider"},{"id":4693081,"accession":"0001562180-25-005794","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001562180-25-005794","line_url":"/filing/0001562180-25-005794#line-2","is_derivative":false,"issuer_cik":"0001644087","issuer_name":"Edgewise Therapeutics, Inc.","issuer_ticker":"EWTX","issuer_name_source":null,"issuer_url":"/issuer/0001644087","owner_cik":"0001644087","owner_name":"Donovan Joanne M.","owner_url":"/insider/0001644087","role":"Officer (CMO)","officer_title":"CMO","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":2862.0,"shares_display":"2,862","price_per_share":13.3924,"price_display":"13.39","price_state":"stated","total_value":38329.0488,"total_display":"38,329.05","shares_owned_after":25361.0,"shares_owned_after_display":"25,361","ownership_form":"D","is_10b5_1":null,"transaction_date":"2025-08-12","filed_date":"2025-08-14","scope":"insider"},{"id":4258938,"accession":"0001562180-25-003657","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001562180-25-003657","line_url":"/filing/0001562180-25-003657#line-2","is_derivative":false,"issuer_cik":"0001644087","issuer_name":"Edgewise Therapeutics, Inc.","issuer_ticker":"EWTX","issuer_name_source":null,"issuer_url":"/issuer/0001644087","owner_cik":"0001644087","owner_name":"Donovan Joanne M.","owner_url":"/insider/0001644087","role":"Officer (CMO)","officer_title":"CMO","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":5187.0,"shares_display":"5,187","price_per_share":16.4542,"price_display":"16.45","price_state":"stated","total_value":85347.9354,"total_display":"85,347.94","shares_owned_after":21588.0,"shares_owned_after_display":"21,588","ownership_form":"D","is_10b5_1":null,"transaction_date":"2025-05-02","filed_date":"2025-05-07","scope":"insider"},{"id":5215284,"accession":"0001562180-25-000697","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001562180-25-000697","line_url":"/filing/0001562180-25-000697#line-2","is_derivative":false,"issuer_cik":"0001644087","issuer_name":"Edgewise Therapeutics, Inc.","issuer_ticker":"EWTX","issuer_name_source":null,"issuer_url":"/issuer/0001644087","owner_cik":"0001644087","owner_name":"Donovan Joanne M.","owner_url":"/insider/0001644087","role":"Officer (CMO)","officer_title":"CMO","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":25000.0,"shares_display":"25,000","price_per_share":27.6263,"price_display":"27.63","price_state":"stated","total_value":690657.5,"total_display":"690,657.50","shares_owned_after":16358.0,"shares_owned_after_display":"16,358","ownership_form":"D","is_10b5_1":null,"transaction_date":"2025-01-28","filed_date":"2025-01-30","scope":"insider"},{"id":2695548,"accession":"0001562180-24-006945","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001562180-24-006945","line_url":"/filing/0001562180-24-006945#line-1","is_derivative":false,"issuer_cik":"0001644087","issuer_name":"Edgewise Therapeutics, Inc.","issuer_ticker":"EWTX","issuer_name_source":null,"issuer_url":"/issuer/0001644087","owner_cik":"0001644087","owner_name":"Donovan Joanne M.","owner_url":"/insider/0001644087","role":"Officer (CMO)","officer_title":"CMO","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":7162.0,"shares_display":"7,162","price_per_share":28.2886,"price_display":"28.29","price_state":"stated","total_value":202602.9532,"total_display":"202,602.95","shares_owned_after":14538.0,"shares_owned_after_display":"14,538","ownership_form":"D","is_10b5_1":null,"transaction_date":"2024-09-20","filed_date":"2024-09-24","scope":"insider"},{"id":3185208,"accession":"0001562180-24-003826","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001562180-24-003826","line_url":"/filing/0001562180-24-003826#line-2","is_derivative":false,"issuer_cik":"0001644087","issuer_name":"Edgewise Therapeutics, Inc.","issuer_ticker":"EWTX","issuer_name_source":null,"issuer_url":"/issuer/0001644087","owner_cik":"0001644087","owner_name":"Donovan Joanne M.","owner_url":"/insider/0001644087","role":"Officer (CMO)","officer_title":"CMO","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":3682.0,"shares_display":"3,682","price_per_share":18.91,"price_display":"18.91","price_state":"stated","total_value":69626.62,"total_display":"69,626.62","shares_owned_after":19897.0,"shares_owned_after_display":"19,897","ownership_form":"D","is_10b5_1":null,"transaction_date":"2024-05-02","filed_date":"2024-05-03","scope":"insider"},{"id":7879037,"accession":"0001562180-23-003919","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001562180-23-003919","line_url":"/filing/0001562180-23-003919#line-2","is_derivative":false,"issuer_cik":"0001644087","issuer_name":"Edgewise Therapeutics, Inc.","issuer_ticker":"EWTX","issuer_name_source":null,"issuer_url":"/issuer/0001644087","owner_cik":"0001644087","owner_name":"Donovan Joanne M.","owner_url":"/insider/0001644087","role":"Officer (CMO)","officer_title":"CMO","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":3254.0,"shares_display":"3,254","price_per_share":8.9049,"price_display":"8.90","price_state":"stated","total_value":28976.5446,"total_display":"28,976.54","shares_owned_after":9960.0,"shares_owned_after_display":"9,960","ownership_form":"D","is_10b5_1":null,"transaction_date":"2023-05-02","filed_date":"2023-05-03","scope":"insider"}],"next_cursor":null,"ledger_fault":false,"count":{"value":17,"kind":"exact"},"open_market_only":false,"composition":{"kind":"exact","rows":[{"code":"P","label":"Open-market purchase","n":0,"open_market":true},{"code":"S","label":"Open-market sale","n":17,"open_market":true},{"code":"M","label":"Option exercise","n":0,"open_market":false},{"code":"A","label":"Grant or award","n":0,"open_market":false},{"code":"F","label":"Tax withholding","n":0,"open_market":false},{"code":"D","label":"Disposition to the issuer","n":0,"open_market":false},{"code":"X","label":"In-the-money option exercise","n":0,"open_market":false}],"total":17},"affiliations":[{"type":"issuer","type_label":"ISSUER","cik":"0001710072","name":"Edgewise Therapeutics, Inc.","url":"/issuer/0001710072","role":"Officer (CMO)","n_filings":11,"first_seen":"2023-05-03","last_seen":"2026-08-14"}],"order_statement":"Newest transaction date first, id breaking the tie.","canonical_url":"https://ebomi.com/insider/0001644087","retrieved_at":"2026-08-21T10:36:00+00:00","coverage":{"filings":1505395,"transactions":4290787,"issuers":28597,"insiders":152303,"first_filed_date":"2003-06-30","last_filed_date":"2026-08-20","last_ingest":"2026-08-21T05:23:33.898496+00:00","counts_are":{"filings":"estimate","transactions":"estimate","issuers":"estimate","insiders":"estimate"},"source":"SEC EDGAR Form 4 filings, parsed by ebomi","fault":false},"license":{"underlying_records":"US SEC filings are public records of the United States government and are not subject to copyright. The transactional facts in them are not ours to license.","this_presentation":"The parsing, normalisation, curation, and presentation are ebomi's own work.","grant":"undecided","grant_note":"The open licence for ebomi's own layer is an open owner decision (SPEC-20260731T1159Z open question 3: CC BY 4.0 or CC0 with a citation request). Until it is taken, no grant is asserted here.","citation_request":"Balogh, A. Insider trading. Scientific Data 10, 237 (2023)","url":"https://ebomi.com/license"},"fair_use":{"policy":"These JSON endpoints are open and unauthenticated. Please read them at a human pace, identify your client in the User-Agent header, and use the published dataset for bulk work rather than crawling page by page.","bulk_alternative":"doi:10.1038/s41597-023-02147-6"}}